Related Experiment Video
Updated: Mar 1, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
957
Prediction model for 30-day morbidity after gynecological malignancy surgery
Seung-Hyuk Shim1, Sun Joo Lee1, Meari Dong1
1Department of Obstetrics and Gynecology, Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul, Korea.
Plos One
|June 2, 2017
Summary
A new nomogram predicts 30-day postoperative morbidity in gynecologic cancer patients using age, operating time, and serum albumin. This tool aids in assessing operative risk for better patient outcomes.
Area of Science:
- Gynecologic Oncology
- Surgical Risk Assessment
- Predictive Modeling
Background:
- Postoperative morbidity in gynecologic cancer patients can delay essential adjunctive therapies and increase healthcare costs.
- Accurate prediction of surgical risk is crucial for optimizing patient management and outcomes.
Purpose of the Study:
- To develop and validate a preoperative nomogram for predicting 30-day postoperative morbidity in patients undergoing gynecologic cancer surgery.
Main Methods:
- A multivariate Cox regression model was used to identify independent predictors of morbidity in 533 patients (2005-2015).
- A nomogram was constructed using significant predictors and validated internally and externally.
- Model performance was evaluated using concordance index and calibration curves.
Main Results:
- The final model identified age, operating time, and serum albumin level as significant predictors of postoperative morbidity.
- The nomogram demonstrated good predictive performance with a concordance index of 0.656 in the development cohort and 0.674 in the validation cohort.
- The nomogram exhibited fair discrimination and good calibration in the validation cohort.
Conclusions:
- Age, operation time, and serum albumin level can predict 30-day morbidity following gynecologic cancer surgery.
- The developed nomogram shows potential as a valuable tool for individual operative risk prediction in gynecologic cancer patients.
- Further external validation is recommended to confirm the nomogram's utility in diverse patient populations.

